drugset / Trial / NCT00274690
Post-Operative Nausea And Vomiting Study In Female Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.
Timeline
- Start
- 2005-02
- Primary completion
- 2005-08
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casopitant | Small molecule | 50 mg | Oral |
| Subject | Casopitant | Small molecule | 150 mg | Oral |
Indications
No indication recorded.